Clinical Trial Detail

NCT ID NCT02985125
Title LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Georgetown University
Indications

pancreatic adenocarcinoma

Therapies

Everolimus + Ribociclib

Age Groups: adult senior

No variant requirements are available.